Avenue Biosciences

About Avenue Biosciences

Avenue Biosciences is a transatlantic biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers. Avenue Biosciences has developed a protein engineering platform for measuring and modulating the efficacy of the protein secretory pathway, a critical bottleneck affecting the development and manufacturing of therapeutic proteins.

  • Country/Region:
    Finland
  • Founded:
    2023
  • On CPHI since:
    2026
  • Employees:
    1 - 24
Company types
Engineering
Start-up
Primary activities
Biopharmaceutical
Contact info
Meet us at

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026

Products from Avenue Biosciences (1)

  • High throughput signal peptide engineering

    Product High throughput signal peptide engineering

    We analyze thousands of signal peptides in parallel for a therapeutic target of interest. Our protein engineering results in significant enhancement in protein expression, yield and quality.